The University of Tokyo and Savid Therapeutics Co., Ltd., a university-launched venture, have developed a new photoimmune agent, FL2, and have succeeded in completely eradicating recurrent breast cancer in mice using this product.

 Photoimmunotherapy is a treatment method that uses a drug that combines an antibody that recognizes cancer cells with a photosensitizer (compound that is activated by light). It is a method that kills cancer cells by causing a chemical reaction in the agent to generate a cell-damaging substance (singlet oxygen).It is being developed as a new treatment method that can treat even advanced cancers that are difficult to remove without surgery, and that can only damage cancer cells where photosensitizers have accumulated, without damaging normal cells and tissues. .

 However, since near-infrared rays have a limited range within the human body, even if the tumor appears to have disappeared with the naked eye after treatment, some cancer cells may still remain and may recur. It was said that it was an issue.

 Therefore, this group has developed a highly effective therapeutic drug that combines a new photoactivator Ax-SiPc that can produce more singlet oxygen than conventional drugs with an antibody mimetic drug that specifically binds to antigens on the surface of tumor cells. Newly developed "FL2".

 When 10 mice transplanted with human breast cancer cells were treated using this, the tumors in all mice decreased rapidly after the first treatment, but 1% (30 mice) after 5 days. recurrence was observed inThen, after the recurrent tumor had grown larger (5 days after treatment), a second treatment was performed. It is said that he discovered that the cells of

 In other words, repeated administration of FL2 induces tumor immunity, suggesting that it may be effective in eradicating light-accessible skin tumors.The results of this research are expected to lead to the establishment of an epoch-making treatment that cures cancer without surgery.

Paper information:[Cancer Science] Pathological complete remission of relapsed tumor by photo-activating antibody–mimetic drug conjugate treatment

Tokyo University

Established in the 10th year of the Meiji era.A university with the longest history in Japan and at the forefront of Japanese knowledge

The University of Tokyo was established in 1877 (Meiji 10) by integrating the Tokyo Kaisei School and the Tokyo Medical School.Since its establishment, it has developed education and research in a unique way in the world as a leading university in Japan and an academic center for the fusion of East and West cultures.As a result, many human resources have been produced in a wide range of fields, and many research achievements […]

University Journal Online Editorial Department

This is the online editorial department of the university journal.
Articles are written by editorial staff who have a high level of knowledge and interest in universities and education.